For the year ending 2025-12-31, OHI had -$494,172K decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income | 609,467 |
| Depreciation and amortization | 325,247 |
| Impairment on real estate properties | 22,610 |
| Straight-line rent and other write-offs | 27,983 |
| Provision (recovery) for credit losses | 2,336 |
| Amortization of deferred financing costs and loss on debt extinguishment | 968 |
| Stock-based compensation expense | 44,189 |
| Gain on assets sold - net | 67,303 |
| Straight-line rent and effective interest receivables | 50,261 |
| Interest paid-in-kind | -13,590 |
| Loss from unconsolidated entities | 6,134 |
| Other non-cash items | 26,281 |
| Contractual receivables | -2,888 |
| Lease inducements | 9,043 |
| Other operating assets and liabilities | -3,207 |
| Net cash provided by operating activities | 878,551 |
| Acquisition of real estate | 683,029 |
| Net proceeds from sale of real estate investments | 282,776 |
| Investments in construction in progress | 33,589 |
| Investment in loan receivables and other | 173,570 |
| Collection of loan principal | 246,593 |
| Investments in unconsolidated entities | 122,088 |
| Distributions from unconsolidated entities in excess of earnings | 12,913 |
| Capital improvements to real estate investments | 80,869 |
| Proceeds from foreign currency forward contracts | -4,240 |
| Receipts from insurance proceeds | 6,831 |
| Net cash used in investing activities | -539,792 |
| Proceeds from long-term borrowings | 1,311,708 |
| Payments of long-term borrowings | 1,896,758 |
| Payments of financing related costs | 27,251 |
| Net proceeds from issuance of common stock | 606,768 |
| Dividends paid | 780,387 |
| (payments for) proceeds from derivative instruments | 2,200 |
| Redemption of omega op units | 6,248 |
| Distributions to omega op unit holders | 43,888 |
| Net cash (used in) provided by financing activities | -838,256 |
| Effect of foreign currency translation on cash, cash equivalents and restricted cash | 5,325 |
| (decrease) increase in cash, cash equivalents and restricted cash | -494,172 |
| Cash and cash equivalents at beginning of period | 548,735 |
| Cash and cash equivalents at end of period | 54,563 |
OMEGA HEALTHCARE INVESTORS INC (OHI)
OMEGA HEALTHCARE INVESTORS INC (OHI)